Literature DB >> 16180982

The need for a formal invalidation process for animal and non-animal tests.

Michael Balls1, Robert Combes.   

Abstract

A plethora of regulations require that many chemicals and chemical products are tested for efficacy and/or toxicity. When permitted to operate effectively and without bias, the ECVAM/ICCVAM/OECD validation process can be used to independently establish that new animal and non-animal test procedures are sufficiently relevant and reliable for their stated purposes and should be considered for regulatory use. However, the validation process is under threat because of vested interests of various kinds, and it is clear that many currently-accepted animal tests and candidate animal and non-animal tests do not, and could never, meet the agreed criteria for necessity, test development, prevalidation, validation and acceptance. We therefore need an invalidation process to parallel and protect the validation process, so that such methods could be independently reviewed and declared irrelevant and/or unreliable for their claimed purposes. An additional advantage of such a process would be that valuable resources would no longer be wasted in attempts to secure the acceptance of inherently inadequate tests.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16180982     DOI: 10.1177/026119290503300301

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  2 in total

1.  The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.

Authors:  Michael Balls; Patric Amcoff; Susanne Bremer; Silvia Casati; Sandra Coecke; Richard Clothier; Robert Combes; Raffaella Corvi; Rodger Curren; Chantra Eskes; Julia Fentem; Laura Gribaldo; Marlies Halder; Thomas Hartung; Sebastian Hoffmann; Leonard Schectman; Laurie Scott; Horst Spielmann; William Stokes; Raymond Tice; Drew Wagner; Valérie Zuang
Journal:  Altern Lab Anim       Date:  2006-12       Impact factor: 1.303

Review 2.  A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426.

Authors:  Susan L Makris; Kathleen Raffaele; Sandra Allen; Wayne J Bowers; Ulla Hass; Enrico Alleva; Gemma Calamandrei; Larry Sheets; Patric Amcoff; Nathalie Delrue; Kevin M Crofton
Journal:  Environ Health Perspect       Date:  2008-08-12       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.